Tag: emergency use authorization
-
Johnson & Johnson (JNJ) May Be Ready to Rebound
Keep an eye on Johnson & Johnson (JNJ). After pulling back from a high of $173.65, it caught support at $161.99. From here, the stock could again test prior highs if the US FDA grants emergency authorization for its vaccine. With a 66% effective rate in protecting against the virus, JNJ applied for emergency use.…
-
Moderna Inc. Could Have Vaccine by December 2020
Keep an eye on Moderna Inc. (MRNA). The COVID-19 vaccine stock is regaining some lost ground. All after CEO Stephane Bancel said the U.S. government could authorize emergency use of the company’s vaccine by December. That is, if the company can produce positive interim results in November from its clinical trial. According to The Wall…